Penumbra stock breaks below 50-day average

Published on 10/01/2026 at 19:21 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Second-quarter revenue rose 14.90 percent to USD 390.05 million. Penumbra stock costs EUR 284.00 on October 1, 2026 versus EUR 281.00.

PEN, US70975L1070, Illustration mit AI erstellt.

Penumbra (ISIN US70975L1070) crossed below its 50-day moving average on September 30, 2026, reaching USD 318.14 against the USD 321.74 average, MarketBeat reports. The technical signal contrasts with double-digit revenue growth in the second quarter of 2026, leaving earnings execution as the sharper investor issue.

Revenue grows, earnings lag

Penumbra generated USD 390.05 million in revenue in the second quarter of 2026, up 14.90 percent from the same quarter of 2025. MarketBeat said the figure exceeded the USD 389.64 million consensus estimate by USD 0.41 million.

The earnings picture was weaker. Adjusted earnings per share came in at USD 0.88 in the second quarter of 2026, below the USD 1.16 consensus estimate by USD 0.28, according to MarketBeat. Revenue therefore beat expectations while earnings per share missed them, a split result that helps explain the market's focus on execution rather than sales momentum.

Hold consensus sets hurdle

MarketBeat reported a consensus Hold rating and an average analyst target of USD 367.07 on September 30, 2026. Three analysts rated the stock Buy and fourteen rated it Hold, giving the target a cautious backdrop rather than a uniform bullish signal.

Penumbra's business is centered on medical devices for neurovascular and peripheral vascular procedures. Its investor-relations page says the company serves hospitals and clinics in more than 100 countries and designs, manufactures and markets products for challenging medical conditions, including stroke care.

Stock trades in after-hours

Penumbra stock was trading at EUR 284.00 at Lang & Schwarz on October 1, 2026 at 7:14 p.m. CEST in after-hours trading, plus 1.07 percent versus the Lang & Schwarz prior close of EUR 281.00 on September 30, 2026. The primary listing is on the NYSE, where the finance quote showed USD 318.67 at 1:20 p.m. ET on October 1, 2026.